Portola Pharmaceuticals, Inc. and Lee’s Pharmaceutical have entered into an agreement to jointly expand the Phase 3 APEX study of betrixaban into China, with an option for Lee’s to negotiate for the commercial rights to the drug in China.
Showing posts with label Anticoagulant. Show all posts
Showing posts with label Anticoagulant. Show all posts
Subscribe to:
Posts (Atom)